ELISpot data indicate that the sum of T-cell responsiveness to Spike + NP prior to vaccination confirms that children included in our cellular assays and classified as not infected based on antibodies and COVID-19 tests were naive to SARS-CoV-2 (Supplementary Table S1). The gene discussed is CHMP5; the disease is COVID-19.